Pharmaxi

What Pharmaxi does

Pharmaxi LLC is a privately held Contract Research Organization (CRO) headquartered in Kyiv, Ukraine, that conducts Phase II-IV clinical trials and late-phase large-scale non-interventional studies on behalf of pharmaceutical, biotechnology, and medical device sponsors. Founded around 2013-2014, the company operates across Ukraine, Poland, and additional European countries, assembling a partner network of more than 30 companies to deliver multi-country studies. Its service portfolio spans clinical operations, site management, regulatory and ethics submissions, contracts management, Trial Master File maintenance, medical writing, biostatistics, project management, vendor management, and data management/IT.

The company's core proprietary technology is OnlineCRF, an in-house Electronic Data Capture (EDC) system that supports remote investigator training, real-time monitoring of patient enrollment and CRF completion, data cleaning workflows, and role-based dashboards for Project Managers, CRAs, and CTLs. OnlineCRF is positioned as a product in its own right on the company's website and is the foundation for Pharmaxi's claimed project transparency and remote-monitoring capabilities. The company also holds TÜV Austria quality certification referenced on its website.

Pharmaxi generates revenue through professional services engagements contracted on a per-study basis, with pricing quoted per scope rather than disclosed publicly. Go-to-market is enterprise B2B via direct client relationships, with named long-tenured sponsor relationships including AbbVie (since 2014, hepatitis C epidemiological multi-country study) and Sanofi. The company is founder-owned with no disclosed institutional funding, and operates with 11-50 employees.

Name

Pharmaxi

Legal name

Pharmaxi LLC

Website

https://pharmaxi.com.ua

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

Pharmaxi is a privately held Ukrainian Contract Research Organization that runs Phase II-IV clinical trials and late-phase non-interventional studies for pharma, biotech, and medical device sponsors across Ukraine, Poland, and other European countries, supported by its proprietary OnlineCRF EDC system and a 30+ partner network.

Ownership category

akta.pro rank

Product category

Contract Research Organization (CRO) Services

NAICS

Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical Development (Phase I–III Trial Design & Execution) (HLAIALAE)

Keywords

• Clinical trial services
• Contract research organization
• Electronic data capture
• Clinical study management
• Regulatory affairs services

Headquarters

HQ city

Kyiv

HQ country

Ukraine

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Clinical Trial Management Services: Professional services revenue from managing Phase II-IV clinical trials and late-phase large-scale non-interventional studies. Services include study design negotiation, site management, regulatory submissions, data management, medical writing, biostatistics, project management, and final study report creation. Services are quoted and contracted on a per-study basis.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Pharmaxi is a Contract Research Organization that manages Phase II-IV clinical trials and late-phase large-scale non-interventional studies for pharmaceutical, biotechnology, and medical device sponsors. Its services span study design negotiation, site management, regulatory and ethics submissions, data management, medical writing, biostatistics, project management, and final study report creation, supported by its proprietary OnlineCRF Electronic Data Capture (EDC) system.

Product overview

Pharmaxi is a mid-sized Contract Research Organization (CRO) offering a unified product-service portfolio centered on OnlineCRF, their proprietary Electronic Data Capture (EDC) system. The company provides integrated clinical trial services spanning study design through final report delivery, including Clinical Operations, Medical Writing, Biostatistics, Regulatory Affairs, Data Management/IT, Project Management, and Vendors Management. OnlineCRF serves as the core technology platform enabling real-time transparency and remote monitoring of trial progress, supported by on-site Site Management services. The company operates across Ukraine, Poland, and other European countries, assembling partnerships with over 30 companies to conduct multi-country studies.

Differentiator

Problem solved

Functional benefit

Brands

• OnlineCRF: Electronic Data Capture (EDC) system developed by Pharmaxi for clinical trial data management, enabling remote monitoring of patient enrollment, CRF completion, and project progress tracking.

Products and services

• Clinical Trial Management Services End-to-end management of Phase II-IV clinical trials and late-phase large-scale non-interventional studies for pharmaceutical, biotechnology, and medical device sponsors. Services span study design negotiation, site feasibility, on-site monitoring (Qualification Visits, SDV, Closeout Visits), Ethics and Regulatory Submissions, Contracts Management, Trial Master File maintenance, data management, medical writing, biostatistics, project management, vendors management, and final study report and TMF delivery.
• OnlineCRF Electronic Data Capture System Proprietary Electronic Data Capture (EDC) platform developed in-house by Pharmaxi for clinical trial data management. Enables remote training of investigators, monitoring of data collection progress, data cleaning, control of patient enrollment, tracking of completed and incomplete CRFs, CRF editing and change reasons, and overall study progress and CRA activity oversight by Project Managers.
• Site Management Services Site feasibility assessment, identification of optimal investigational sites, and ongoing site management and support, including on-site Qualification Visits, Source Data Verification (SDV), and Closeout Visits executed by qualified Pharmaxi personnel.
• Medical Writing Services Preparation of clinical and regulatory documentation including Standard Operating Procedures, Clinical Study Reports, Pharmacovigilance Reports, Study Protocols, Investigator Brochures, Informed Consent Forms, and Case Report Forms.
• Biostatistics Services Statistical analysis support for clinical trials, delivered as a standalone service or integrated within full-service clinical trial management.
• Regulatory Affairs Services Local Ethics and Regulatory Submissions management across supported European countries, supporting clinical trial authorization and ongoing compliance.
• Data Management and IT Services Clinical database design and management, including data collection progress monitoring and data cleaning, supported by Pharmaxi's proprietary OnlineCRF EDC system.
• Project Management Services Dedicated Project Manager oversight of overall study progress, CRA activity, and cross-functional coordination across clinical trial teams.
• Vendors Management Services Coordination and oversight of subcontracted vendors (e.g., drug depot, logistics, insurance) and assembled partner companies to support multi-country clinical trial execution, including activities not covered by Pharmaxi's in-house facilities.

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Others

• Veeva Systems: Provider of cloud-based life sciences software including EDC and CTMS platforms used by CROs and sponsors. Comparable as a vendor competing in the EDC/data management space where Pharmaxi's OnlineCRF operates, though Veeva sells standardized software rather than running trials.
• Medidata Solutions: Dassault Systèmes subsidiary providing the Medidata Rave EDC and CTMS platforms widely used in clinical trials. Relevant as a competing technology provider to Pharmaxi's proprietary OnlineCRF system in the EDC and data management category.

Broad incumbents

• Medpace: Mid-to-large CRO focused on Phase II-IV clinical trials across multiple therapeutic areas, similar to Pharmaxi's stated focus on Phase II-IV and late-phase studies. Both target biotech and pharma sponsors seeking full-service clinical management.
• IQVIA: Global Tier-1 CRO offering full clinical trial services across all phases, including EDC/data management platforms. Comparable as the dominant incumbent competing for the same pharma/biotech sponsors Pharmaxi serves, though at much greater scale.
• Syneos Health: Biopharmaceutical services organization combining CRO and commercialization capabilities. Comparable to Pharmaxi as a clinical trial services provider targeting pharma and biotech sponsors across multiple geographies.
• Parexel International: Global CRO offering biopharmaceutical services including clinical trial management, biostatistics, and regulatory consulting. Directly comparable in service mix to Pharmaxi, though operating at a global enterprise scale.
• ICON plc: Large global CRO providing Phase I-IV clinical research, biometrics, and centralized lab services. Directly comparable to Pharmaxi's full-service clinical operations model but at global scale with vastly greater headcount and capital.
• Charles River Laboratories: Global CRO and preclinical/research services provider. Comparable as a clinical trial services company serving pharma and biotech clients, with broader preclinical portfolio but overlapping Phase II-IV capability.

Direct peers

• Worldwide Clinical Trials: Mid-sized global CRO focused on Phase II-IV clinical trials across multiple therapeutic areas. Comparable to Pharmaxi in positioning as a flexible, mid-sized CRO serving pharmaceutical and biotech sponsors with full-service trial management.
• Novotech (Novotech Health Holdings): Asia-Pacific-headquartered CRO with expanding European presence, focused on biotech sponsors and Phase I-IV trials. Comparable to Pharmaxi as a regional CRO scaling into multi-region coverage with cost-attractive positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/Pharmaxi_ua
• Facebookfacebook.com/pharmaxi.ua

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharmaxi